MAPT and Alzheimer disease: However, there remain significant limitations in identifying the mechanisms that lead to the distinct tauopathy of AD (in humans)-i.e., the facilitation of tau aggregation and spread by Aβ plaques (particularly neuritic plaques), as well as the mechanisms linking the excretion of hyperphosphorylated, soluble tau to Aβ plaques.